Neumora Therapeutics, Inc. (NMRA)
0.73
-0.02
(-2.67%)
USD |
NASDAQ |
Sep 18, 16:00
0.7219
-0.01
(-1.11%)
After-Hours: 20:00
Neumora Therapeutics Price to Book Value : 3.064 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.064 |
| September 17, 2026 | 3.148 |
| September 16, 2026 | 3.245 |
| September 15, 2026 | 3.489 |
| September 14, 2026 | 4.195 |
| September 11, 2026 | 4.365 |
| September 10, 2026 | 4.785 |
| September 09, 2026 | 5.036 |
| September 08, 2026 | 5.246 |
| September 04, 2026 | 5.498 |
| September 03, 2026 | 5.666 |
| September 02, 2026 | 5.792 |
| September 01, 2026 | 5.582 |
| August 31, 2026 | 5.582 |
| August 28, 2026 | 5.834 |
| August 27, 2026 | 6.212 |
| August 26, 2026 | 6.548 |
| August 25, 2026 | 6.296 |
| August 24, 2026 | 6.401 |
| August 21, 2026 | 6.841 |
| August 20, 2026 | 6.359 |
| August 19, 2026 | 6.883 |
| August 18, 2026 | 6.883 |
| August 17, 2026 | 6.380 |
| August 14, 2026 | 6.715 |
| Date | Value |
|---|---|
| August 13, 2026 | 7.261 |
| August 12, 2026 | 7.177 |
| August 11, 2026 | 7.135 |
| August 10, 2026 | 6.799 |
| August 07, 2026 | 6.841 |
| August 06, 2026 | 6.883 |
| August 05, 2026 | 6.757 |
| August 04, 2026 | 6.715 |
| August 03, 2026 | 6.883 |
| July 31, 2026 | 6.757 |
| July 30, 2026 | 6.925 |
| July 29, 2026 | 6.925 |
| July 28, 2026 | 7.051 |
| July 27, 2026 | 6.967 |
| July 24, 2026 | 6.254 |
| July 23, 2026 | 6.548 |
| July 22, 2026 | 6.464 |
| July 21, 2026 | 6.778 |
| July 20, 2026 | 6.841 |
| July 17, 2026 | 6.757 |
| July 16, 2026 | 6.715 |
| July 15, 2026 | 6.841 |
| July 14, 2026 | 6.631 |
| July 13, 2026 | 6.715 |
| July 10, 2026 | 7.051 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioAge Labs, Inc. | 0.9841 |
| LB Pharmaceuticals, Inc. | 3.665 |
| ANI Pharmaceuticals, Inc. | 2.929 |
| Corcept Therapeutics, Inc. | 16.86 |
| Veru, Inc. | 1.448 |
Price to Book Value Related Metrics
| Price | 0.73 |
| Earnings Yield | -169.0% |
| Market Cap | 136.40M |